Kevin Lee insider trades

Open-market stock purchases and sales by Kevin Lee, CHIEF EXECUTIVE OFFICER at Bicycle Therapeutics plc, from SEC Form 4 filings since May 28, 2019.

Recent trades

DateStockTradeValue
Oct 5, 2026BCYC Bicycle Therapeutics plcSold$5.8K
Oct 2, 2026BCYC Bicycle Therapeutics plcSold$21.4K
Jul 6, 2026BCYC Bicycle Therapeutics plcSold$7.5K
Jul 2, 2026BCYC Bicycle Therapeutics plcSold$25.2K
Apr 6, 2026BCYC Bicycle Therapeutics plcSold$8.7K
Apr 2, 2026BCYC Bicycle Therapeutics plcSold$29.3K
Jan 5, 2026BCYC Bicycle Therapeutics plcSold$71K
Jan 2, 2026BCYC Bicycle Therapeutics plcBought (not open market)—
Jan 2, 2026BCYC Bicycle Therapeutics plcSold$70.2K
Jan 2, 2026BCYC Bicycle Therapeutics plcBought (not open market)—

Companies traded

  • BCYC Bicycle Therapeutics plc: 73 sales, last Oct 5, 2026

Get free alerts when Kevin Lee files a new trade →